Search

everythinglearnresearchcommunity

for

Search:↓

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Ebola affected children less severely than adults, but better control measures and data collection are needed.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Low testosterone increases kidney stone risk in men not on testosterone therapy.

A man with KID syndrome developed a rare cancer in a long-term skin infection.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Hair loss in men is common, treatable, but not curable.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

A woman showed neurological symptoms from psittacosis linked to bird exposure, improving after antibiotic treatment.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Suppressing certain hormones might help prevent prostate cancer.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.